We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Phase 2 Trials Underway for New Single Dose Malaria Treatment

News   Aug 12, 2015

 
Phase 2 Trials Underway for New Single Dose Malaria Treatment
 
 
 

RELATED ARTICLES

Scientists Discover Intricacies of Serotonin Receptor Crucial for Better Drugs

News

Researchers have figured out precisely why one drug binds to the serotonin receptor 5-HT2BR and activates it to cause heart problems while very similar drugs do not. They've also discovered why a third drug acts like a 5-HT2BR antagonist - it blocks the receptor's activity - while the very well-known similar hallucinogenic drug LSD does not.

READ MORE

Antibiotic Candidates Discovered

News

MIT researchers have discovered that peptides normally secreted by cells that line the stomach have previously unknown antimicrobial activity.

READ MORE

Molecular Switch May Serve as New Target for Cancer and Diabetes Therapies

News

If certain signaling cascades are misregulated, diseases like cancer, obesity and diabetes may occur. A recently discovered mechanism has a crucial influence on such signaling cascades and may be an important key for the future development of therapies against these diseases.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE